The In Vitro Diagnostic Medical Devices Regulation (IVDR) is the landmark European legislation governing diagnostic tests and medical devices. Replacing the outdated In Vitro Diagnostic Directive (IVDD), the IVDR modernizes rules to ensure higher safety and accuracy standards across the EU market. It introduces a stricter, risk-based classification system and mandates rigorous clinical evidence for all diagnostic products.
Purpose: To protect patient health by ensuring tests from glucose monitors to genetic kits are safe and accurate.
Business Relevance: Compliance is the prerequisite for CE marking. Without it, you cannot legally generate revenue in the EU.
Regulatory Shift: Unlike the old system where 80% of devices were self-certified, the IVDR requires independent Notified Body oversight for roughly 85% of IVDs.
Risks: Non-compliance leads to product recalls, loss of market access, and severe financial penalties.
The regulation applies to all economic operators in the IVD lifecycle, including:
Manufacturers: Global or EU-based companies.
Importers & Distributors: Businesses bringing devices into the EU or distributing them.
Authorized Representatives (EC REP): Legal liaisons for non-EU manufacturers.
Health Institutions: Laboratories manufacturing specialized "in-house" tests.
Classification: Assessing risk (Class A, B, C, or D).
Quality Management (QMS): Establishing an ISO 13485-aligned system.
Performance Evaluation: Compiling a Performance Evaluation Report (PER) backed by clinical evidence.
Post-Market Surveillance (PMS): Continuous monitoring of device safety after launch.
PRRC: Appointing a Person Responsible for Regulatory Compliance.
UDI: Implementing Unique Device Identification for traceability.
Classify: Determine your device’s risk category.
Gap Analysis: Audit your current technical files against IVDR requirements.
Upgrade QMS: Ensure your management system meets current standards.
Clinical Data: Document performance via the PER.
Notified Body: Secure a contract for conformity assessment (for Class B–D).
Certification: Obtain your CE mark and register in EUDAMED.
Starting Too Late: Transitioning takes 12–24 months; waiting causes market exit.
Misclassification: Choosing the wrong class leads to incorrect regulatory pathways.
Insufficient Clinical Data: Relying on outdated literature instead of objective performance data.
Ignoring PMS: Failing to build a proactive post-market strategy.
Not Booking a Notified Body: High demand has created a capacity shortage; book early.
Compliance secures your European market access and mitigates supply chain risks. Furthermore, meeting these high standards builds trust with healthcare providers and provides a competitive global advantage.
MedTest Innovations, a manufacturer of diagnostic swabs, moved from self-certification (under IVDD) to Class C (under IVDR). To maintain sales, they appointed an EU Authorized Representative, updated their QMS, gathered new performance data, and passed a Notified Body audit. They are now fully IVDR-compliant and continue to sell legally across Europe.
The mandatory EU regulation for diagnostic medical devices.
Any business manufacturing or selling IVDs in the EU.
Yes, it is the law for EU market access.
Variable; typically €20,000 to €150,000+ depending on device complexity.
You lose your right to sell in the EU and face potential recalls.
IVDR is much stricter, requiring independent audits for most devices.
Classes A (low) through D (highest risk).
Yes, for all classes except low-risk Class A (non-sterile).
The mandatory EU database for device registration and incident reporting.
Yes, software used for diagnostic purposes is subject to IVDR.
MDR, Notified Body, CE Marking, EUDAMED, PMS, PER, PRRC, ISO 13485, EC REP, UDI.
Transitioning to the IVDR is complex. At Complico Consulting GmbH, we specialize in simplifying European compliance. From gap assessments to Notified Body negotiations, our experts ensure your business remains compliant and competitive.
